Third Rock Ventures Iii, L.P. Revolution Medicines, Inc. (RVMD) insider trading activity

Third Rock Ventures Iii, L.P. is > 10% Shareholder of Revolution Medicines, Inc.. Currently has a direct ownership of 5.1 Million shares of RVMD, which is worth approximately $290 Million. The most recent transaction as insider was on Jun 08, 2022, when has been sold 419,901 shares (Common Stock) at a price of $20.25 per share, resulting in proceeds of $8,502,995. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.1M

0% 3M change

0% 12M change

Total Value Held $290 Million

Third Rock Ventures III, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 08 2022	SELL Open market or private sale	$8,502,995 $20.25 p/Share	419,901 Reduced 7.6%	5,104,130 Common Stock
Feb 24 2021	SELL Other acquisition or disposition	-	1,500,000 Reduced 21.36%	5,524,031 Common Stock
Dec 02 2020	SELL Other acquisition or disposition	-	1,000,000 Reduced 12.46%	7,024,031 Common Stock
Sep 09 2020	SELL Other acquisition or disposition	-	1,000,000 Reduced 11.08%	8,024,031 Common Stock
Feb 18 2020	BUY Conversion of derivative security	-	10,522,342 Added 84.64%	1,909,317 Common Stock

Also insider at

MYOK

MyoKardia Inc

> 10% Shareholder

VYGR

Voyager Therapeutics, Inc. Healthcare

> 10% Shareholder

NTGN

Neon Therapeutics, Inc.

> 10% Shareholder

FULC

Fulcrum Therapeutics, Inc. Healthcare

> 10% Shareholder

PLRX

PLIANT THERAPEUTICS, INC. Healthcare

> 10% Shareholder

RLAY

Relay Therapeutics, Inc. Healthcare

> 10% Shareholder

NRIX

Nurix Therapeutics, Inc. Healthcare

> 10% Shareholder

JNCE

Jounce Therapeutics, Inc. Healthcare

> 10% Shareholder

TRV